FDA continues the investigation of Cronobacter infections in Abbott’s powdered infant formula while allowing the limited release of products

The FDA, CDC, and state and local partners investigate consumer complaints and reports of infant illness received from 9/20/2021 to 1/11/2022 related to products from Abbott Nutrition's Sturgis, MI, facility. The four ill patients reported consuming powdered infant formula produced from Abbott Nutrition's Sturgis, MI, facility. Following the recall of powdered infant formula products produced at the Abbott Nutrition facility in Sturgis, MI, Abbott has committed to completing enhanced testing of stored product batches before making release determinations. Until final testing is completed, the FDA has informed Abbott Nutrition that the agency has no objection to the company immediately releasing products to individuals needing urgent, life-sustaining supplies of the specialty and metabolic formulas on a case-by-case basis. Allowing parents to access these products may outweigh the potential risk of bacterial infection. The FDA continues to work to ensure the safe resumption of infant formula production at Abbott Nutrition's Sturgis, Michigan facility. The FDA advises consumers not to use recalled Similac, Alimentum, or EleCare powdered infant formulas.  https://www.fda.gov/food/outbreaks-foodborne-illness/fda-investigation-cronobacter-infections-powdered-infant-formula-february-2022?utm_medium=email&utm_source=govdelivery